| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO and CFO | Interim CEO and CFO | CFO +1 more
1 company
Thomas Ronan Kennedy is CEO and CFO at YCBD. Thomas Ronan Kennedy's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $215K at current prices.
Net of sales, the YCBD filings show accumulation of 12,400 shares.
Thomas Ronan Kennedy has 8 Form 4 filings on record from October 2020 to November 2025, all as CEO and CFO at cbdMD (YCBD), 2020–2025.
The 22 reported transactions were 13 option or other derivative awards, 5 open-market purchases, 2 stock awards and 1 conversion, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 2 purchases worth about $26K and no sales.
The largest open-market purchase was 7,400 shares of YCBD at an average $2.04 on August 24, 2021, about $15K. Twelve months later YCBD was down 78%.